Mineralys Therapeutics, Inc. (MLYS) NASDAQ
28.49
-0.44(-1.52%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
28.49
-0.44(-1.52%)
Currency In USD
| Market Cap | 2.46B |
| Enterprise Value | 2.28B |
| P/E Ratio | -14.84 |
| PEG Ratio | -0.35 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 3.55 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | -10.31 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | December 31, 2025 |
| Profit Margin | 0 |
| Operating Margin | 0 |
| Return On Assets | -0.23 |
| Return On Equity | -0.33 |
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | -59,000 |
| EBITDA | -170.6M |
| Net Income | -154.65M |
| Diluted EPS | -2.29 |
| Total Cash | 656.64M |
| Total Cash/Share | 8.15 |
| Total Debt | 0 |
| Total Debt/Equity | 0 |
| Current Ratio | 43.76 |
| Book Value Per Share | 8.03 |
| 52-Week Change | 110.57 |
| 52-Week High | 47.65 |
| 52-Week Low | 12.59 |
| Moving Average 50 Days | 27.35 |
| Moving Average 200 Days | 30.55 |
| Average Volume | 1.23M |
| Shares Outstanding | 66.3M |
| % Held by Institutions | 125.2 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |